期刊文献+

欧前胡素对顺铂的骨肉瘤细胞抗肿瘤作用的增效作用 被引量:13

Anti-tumor Effect and Mechanism of Imperatorin Enhances the Cytotoxicity of Cisplatin Osteosarcoma Cells
原文传递
导出
摘要 目的研究欧前胡素是否能提高人骨肉瘤细胞(human osteosarcoma cells,HOS细胞)对顺铂的敏感性。方法 HOS细胞用欧前胡素和顺铂处理,MTT法检测体外细胞活力,Western blot检测Bcl-2蛋白家族成员(Mcl-1、Bcl-2、Bcl-xl、Bad和Bax)的表达水平,流式细胞术检测细胞凋亡水平和线粒体膜电位的变化情况。构建Mcl-1真核表达载体,MTT法检测Mcl-1表达载体转染对欧前胡素联合顺铂治疗骨肉瘤疗效的影响。结果欧前胡素在体外可显著提高顺铂对骨肉瘤细胞系HOS的杀伤活性。欧前胡素可显著降低HOS细胞Mcl-1的表达,而顺铂对Mcl-1的表达水平无影响。相比于欧前胡素或顺铂单治疗组,两者联合可显著诱导HOS细胞发生凋亡并降低其线粒体膜电位。体外转染Mcl-1真核表达载体显著降低顺铂联合欧前胡素对HOS细胞的杀伤活性。结论欧前胡素通过靶向于Mcl-1增强顺铂对骨肉瘤细胞的杀伤活性。 OBJECTIVE To study the effect of the addition of imperatorin in cisplatin therapy in osteosarcoma(HOS cells) in vitro. METHODS HOS cells were treated with imperatorin and cisplatin, and then their viability was determined by MTT assay in vitro, the expression of Bcl-2 protein family(Mcl-1, Bcl-2, Bcl-xl, Bad and Bax) was evaluating by Western blot, and flow cytometry was used for apoptosis detection and measurement of mitochondrial membrane potential. Construct Mcl-1 expression vector, and then detected the role of Mcl-1 vector toward imperatorin plus cisplatin–inducing cytotoxicity in HOS cells by MTT assay. RESULTS Addition of imperatorin significantly enhanced the cytotoxicity of cisplatin to HOS cells in vitro. Mcl-1 expression was down-regulated by imperatorin but not influenced by cisplatin in HOS cells. A combination of imperatorin and cisplatin induced apoptosis and mitochondrial membrane potential collapse more significantly compared with treatment of imperatorin or cisplatin alone. Furthermore, the imperatorin-induced sensitization for cisplatin-cytotoxicity to HOS cells was abolished by the transfection of Mcl-1 expression plasmid. CONCLUSION Combination with imperatorin can enhance the anti-tumor activity of cisplatin to osteosarcoma cells via targeting Mcl-1.
出处 《中国现代应用药学》 CAS CSCD 2015年第10期1193-1197,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 欧前胡素 顺铂 MCL-1 骨肉瘤 imperatorin cisplatin Mcl-1 osteosarcoma
  • 相关文献

参考文献21

  • 1RAD M P, FATTAHI MASOUM S H, RAD M S, et al. Primary osteosarcoma of the sternum: a case report and review of the literature [J]. Arch Bone Jt Surg, 2014, 2(4): 272-275. 被引量:1
  • 2ANDO K, HEYMANN M F, HEYMANN D, et al. Current therapeutic strategies and novel approaches in osteosarcoma [J]. Cancers (Basel), 2013, 5(2):591416. 被引量:1
  • 3王朝阳,王莹,丁丽宏,周静.shRNA沉默STAT3基因对结肠癌细胞增殖及顺铂敏感性的影响[J].中国现代应用药学,2013,30(12):1276-1280. 被引量:1
  • 4PETRELLI F, DE STEFANI A, BARNI S, et al. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and recta-analysis [J]. Gynecol Oncol, 2014, 134(1):166-171. 被引量:1
  • 5ZHOU N, ZHANG Y, HE L, et al. The imperatorin derivative OWl, a new vasoactive compound, inhibits VSMC proliferation and extracellular matrix hyperplasia [J]. Toxicol Appl Pharmacol, 2015, 284(2): 125-133. 被引量:1
  • 6WANG Y W, YANG C T, LEUNG Y M, et al. Inhibitory effects of imperatorin on voltage-gated K(+) channels and ATP-sensitive K(+) channels [J]. Pharmacol Rep, 2015, 67(1): 134-139. 被引量:1
  • 7ZHANG Y, CAO Y, HE L, et al. Furanocoumarins- imperatorin inhibits myocardial hypertrophy both in vitro andin vivo [J]. Fitoterapia, 2010, 81(8): 1188-1195. 被引量:1
  • 8CHOOCHUAY K, CHUNHACHA P, CHANVORACHOTE P, et al. Imperatorin sensitizes anoikis and inhibits anchorage- independent growth of lung cancer cells [J]. J Nat Med, 2013, 67(3): 599-606. 被引量:1
  • 9LUO K W, SUN J G, LIU F Y, et al. Anticancer effects of imperatorin isolated from Angelica dahurica: induction of apoptosis in HepG2 cells through both death-receptor- and mitochondria-mediated pathways [J]. Chemotherapy, 2011, 57(6): 449-459. 被引量:1
  • 10BADZIUL D, JAKUBOWICZ-GIL J, GAWRON A, et al. Combined treatment with quercetin and imperatorin as a potent strategy for killing HeLa and Hep-2 cells [J]. Mol Cell Biochem, 2014, 392(1/2): 213-227. 被引量:1

二级参考文献1

同被引文献119

引证文献13

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部